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Abstract: T-cell development in the thymus is a complex and highly regulated process, involving
a wide variety of cells and molecules which orchestrate thymocyte maturation into either CD4+ or
CD8+ single-positive (SP) T cells. Here, we briefly review the process regulating T-cell differentiation,
which includes the latest advances in this field. In particular, we highlight how, starting from a pool
of hematopoietic stem cells in the bone marrow, the sequential action of transcriptional factors and
cytokines dictates the proliferation, restriction of lineage potential, T-cell antigen receptors (TCR) gene
rearrangements, and selection events on the T-cell progenitors, ultimately leading to the generation
of mature T cells. Moreover, this review discusses paradigmatic examples of viral infections affecting
the thymus that, by inducing functional changes within this lymphoid gland, consequently influence
the behavior of peripheral mature T-lymphocytes.
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1. Introduction
The thymus gland is a primary lymphoid organ, in which the essential development of T cells
occurs. Within the thymus, hematopoietic precursors, deriving from bone marrow, enter the route of
differentiation that will generate αβ- or γδ- mature T cells. Finally, these cells will exit the thymus and
will colonize secondary lymphoid organs, where they will provide immunity against specific antigens.
The murine thymus has two lobes that are divided into multiple lobules by connective tissue,
made of fibroblasts, collagen, and elastic fiber, as does the human thymus. The basic structural unit of
the thymus is the lobule, composed of two distinct areas, the cortex and the medulla [1]. Each lobe has
an outer cortex and an inner medulla. The cortex is densely populated by immature T-lymphocytes,
while the medulla contains only a few mature T-lymphocytes.
The thymus medulla contains some Hassall’s corpuscles that are populated by eosinophilic
type-VI epithelial reticular cells arranged concentrically, containing keratohyalin and bundles of
cytoplasmic fibers (Figure 1). These cells differentiate from medullary thymic epithelial cells, following
the inactivation of the autoimmune regulatory (AIRE) gene.
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A third compartment can be found in the thymus, defined as the perivascular space (PVS). This
compartment, despite surrounding blood vessels within the capsule, is physically separated from the
thymic epithelial space. The role of the PVS has been often overlooked, due to its minimal extension
during infancy and because it does not appear to be a functional site actively involved in thymopoiesis.
However, as the thymus ages, the PVS enlarges and progressively replaces the epithelial area [2].
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(yellow), contribute to the tissue organization. In humans, during the maturation process, bone 
marrow-derived T-cell progenitors arrive in the thymus via the bloodstream, where cTEC cells 
contribute to positive selection maturation, and mTEC cells contribute to the negative selection 
process, respectively. Also, DCs are likely responsible for negative selection in the cortex. Once the 
selection has been successfully completed and self-reactive cells have been removed by apoptosis, 
mature CD4+ or CD8+ T cells leave the thymus to populate the peripheral blood and secondary 
lymphoid organs. Viral infections are able to affect thymus functionality in multiple ways, but the 
most severe effects are observed when positive or negative selection is impaired, as these processes 
drive key steps of T-cell development. In the figure, lightning bolts indicate which viruses can 
specifically target and influence the activity of cTEC or mTEC populations. 
Thymic natural killer (NK) cells arise from early thymocyte precursors, and their development 
strictly relies on Interleukin-7 (IL7) signaling and requires the transcription factor GATA-3 [3–5]. 
Thymic NK cells are cytotoxic and characterized by the expression of CD127 (IL-7 receptor α). CD1-
d restricted invariant Natural Killer T (iNKT) cells are a major producer of cytokines within the 
thymus, such as IFNγ and IL-4. Specifically, IL4, produced in combination with IL-13, triggering 
type-2 IL-4R signaling, is a key regulator of the migration during development [6]. 
In mice, three subsets of iNKT cells (NKT1-2-3) have been characterized. NKT2 are responsible 
for the IL-4 secretion, reside in the thymic medulla, and secrete cytokines even after infection in order 
to regulate and induce the development of the surrounding immune cells [7]. Thymic NK cells are, 
indeed, essential for the modulation of thymopoiesis and the maintenance of thymic architecture, 
and, also have a role in dendritic cell (DC) maturation [8]. 
Interestingly, the thymus contains macrophages and dendritic cells that originate from the bone 
marrow and arrive in the gland through blood vessels. More specifically, at least three different 
populations of macrophages have been identified within the thymus: dendritic, round, and flat-
shaped cells (Table 1). Dendritic macrophages are randomly distributed throughout the thymus and 
are positive to markers Mac-2 and F4/80; flat-shaped macrophages (F4/80+, CD32/16+, Mac-2−) are 
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thymic epithelial cells (TECs) are present in the thymic parenchyma. In particular, cortical TEC
(cTEC) cells are identified in the cortical compartment of the parenchyma, whereas medullary TEC
(mTEC) cells are located internally. Dendritic cells (DCs, shown in green), fibroblasts (blue) and
macrophages (yellow), contribute to the tissue organization. In humans, during the maturation process,
bone marrow-derived T-cell progenitors arrive in the thymus via the bloodstream, where cTEC cells
contribute to positive selection maturation, and mTEC cells contribute to the negative selection process,
respectively. Also, DCs are likely responsible for negative selection in the cortex. Once the selection has
been successfully completed and self-reactive cells have been removed by apoptosis, mature CD4+
or CD8+ T cells leave the thymus to populate the peripheral blood and secondary lymphoid organs.
Viral infections are able to affect thymus functionality in multiple ways, but the most severe effects are
observed when positive or negative selection is impaired, as these processes drive key steps of T-cell
development. In the figure, lightning bolts indicate which viruses can specifically target and influence
the activity of cTEC or mTEC populations.
Thymic natural killer (NK) cells arise from early thymocyte precursors, and their development
strictly rel es on Inter eukin-7 (IL7) signaling and requires th t anscription factor GATA-3 [3–5].
Thymic NK cells are cytotoxic and characterized by the expression of CD127 (IL-7 receptor α). CD1-d
restricted invariant Natural Killer T (iNKT) cells are a major producer of cytokines within the thymus,
such as IFNγ and IL-4. Specifically, IL4, produced in combinati n with IL-13, triggeri g type-2 IL-4R
signaling, is a key regul tor of the migration during development [6].
In mice, three subsets of iNKT cells (NKT1-2-3) have bee characterized. NKT2 are responsible
for the IL-4 secretion, reside in the thymic medulla, and s cr te cytokines even after infection in order
t regulate and induc the development of the surrounding immune cells [7]. Thymic NK cells are,
ind ed, esse tial for the mo ulation of thymopoiesis and the maintenance of thymic ar hitecture, nd,
also hav a role in dendritic cel (DC) maturation [8].
Interestingly, the thymus contains macroph ges and dendritic cells that originate from the bone
marrow and arrive in the gland hrough blood vessels. Mo e specifically, at least three different
populatio s of macrophages have been identified within the thymus: dendritic, round, and flat-shaped
cells (Table 1). Dend itic macrophages are randomly distributed throughout the thymus and are positive
to markers Mac-2 and F4/80; flat-shaped macroph ges (F4/80+, CD32/16+, Mac-2−) are distribute
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under the thymic cortex capsule; small oval macrophages, identified using the anti-Mac-2 antibody,
are distributed in the thymic medulla and corticomedullary region (CMR) [9,10]. Thymic dendritic
cells can be subdivided into conventional DC (cDC) (CD11chi, MHC II+, CD45RA−) and plasmacytoid
DC (pDC) (CD11cmedium MHC IIlow, CD45RAhigh, CD45Rhigh). Moreover, conventional DCs can be
further subdivided into CD8α+ and signal regulatory protein α+ (SIRPα+) cDC [11,12] (Table 1).
Table 1. Thymus parenchymal populations.
Cell Type Maturation State/Phenotype References
Dendritic macrophages CD45+, F4/80+, Mac-2+ [9,10]
Flat-shaped macrophages F4/80+, CD32/16+, Mac-2− [9,10]
Small oval macrophages Mac-2+ [9,10]
Type 1 Conventional dendritic cells CD11chigh, MHC II+, CD45RA−, CD8α+ [11,12]
Type 2 Conventional dendritic cells CD11chigh, MHC II+, CD45RA−, SIRPα+ [11,12]
Plasmacytoid dendritic cells CD11cmedium MHC IIlow, CD45RAhigh, CD45Rhigh [11,12]
cTECs CD45–, EpCAM+, Ly51+, K8+, K5–, K14– [13–18]
mTECs CD45–, EpCAM+, Ly51–/low, CD80high, K8–, K5+, K14+ [13–18]
Sphere-forming TEC FoxN1- [19]
Thymic nurse cells K5+, K8+, pH91+ [20–22]
About 0.3% of thymic cells are B cells, a proportion that is comparable to the dendritic cells (Table 2).
Thymic B cells are mainly located within the medulla and at the cortico–medullary junction. Some
evidence suggests that they could develop intra-thymically, do not re-circulate and, harbor a distinct
phenotype in comparison to peripheral B cells. Early disruption of T-cell development [23], as reported
for TCRβ−/− or CD3−/− knock-out mice [23], as well as the disruption of the Notch signaling pathway,
leads to an outgrowth of thymic B-cell progenitors and mature thymic B cells [24,25]. However, by
using a murine model in which Cpa3-Cre causes deletion of Notch1 during the Double Negative 1–2
(DN1-DN2) stage of early T-cell development, Feyerabend et al. showed that thymic B cells deriving
from the disruption of Notch signaling are phenotypically distinct from the B cells observed in the
thymus of wild-type mice [26]. In addition, most of the cells that phenotypically resembled wild-type
mature thymic B cells carried a functional copy of Notch. Hence, these data could indicate that upon
a block of T-cell differentiation, T-cell progenitors do not simply switch toward a thymic-B cell fate,
and that thymic T- and B-cell lineages diverge very early, even before the DN1-2 stage of early T-cell
development [26,27]. Conversely, Yamano et al. more recently demonstrated that thymic B cells are
simply thymus-migrated cells that participate in antigen presentation [28].
Table 2. Thymic cells.
Cell Type Phenotype References
Thymic NK cells CD127 (IL-7 receptor α) [3–8]
iNKT cells CD1d-restricted Thymic NKcells [6,7]
TSP type 1—Fetal BM-derived hematopoietic
progenitors as thymus colonizing cells CD34
high, CD45RAhigh, CD7+ [29]
TSP type 2—Have the capacity to develop into B cells,
NK cells and T cells using in vitro co-culture systems Lin
−, CD34+, CD10+, CD24− [30]
TSP type 3—Possess full lymphoid and monocytic
potential, but lack erythroid potential
Lin−, CD34+, CD10−,
CD45RA+, CD62Lhigh [31]
Double Negative 1 CD34−, CD38−, CD1a+ [31]
Double Negative 2 CD34−, CD38+, CD1a+ [31]
Double Negative 3 CD34+, CD38+, CD1a+ [31]
Double Negative 4—Immature single positive CD3−, CD4+ [31]
Double Positive CD3+, CD4+, CD8+ [16,17,19,32–35]
Single Positive CD3
+, CD4+, CD8−/CD3+,
CD4−, CD8+ [31–38]
B-cells CD19+ [23–28]
Viruses 2019, 11, 836 4 of 19
The thymic parenchyma provides the mechanical support, and includes immune and epithelial
cells, such as lymphocytes, dendritic macrophages, dendritic cells, fibroblasts, matrix molecules
(laminin, fibronectin, collagen, lectins), and hormones (thymulin, thymopoietin, thymosin-α1).
Depending on the localization, in the thymic cortex or medulla, thymic epithelial cells (TECs)
(CD45−, EpCAM+) are classified as cortical or medullary TECs (cTECs and mTECs, respectively).
Specific progenitors for medullary TECs (mTECs) and cortical TECs (cTECs), as well as common
medullary/cortical bipotent progenitors, have been identified from embryonic mouse thymus [13–16].
mTEC progenitors were initially identified by Rodewald et al., showing how the murine thymic
medulla owns small groups of TECs (islets), each deriving from a single progenitor [13]; whereas, Bleul
et al. and Rossi et al. showed the existence of medullary/cortical bipotent TEC progenitors even in the
adult thymus [15,17].
More recently, rare sphere-forming cells (FoxN1−) have been identified in thymic stromal cells
of the adult mouse thymus. These cells display several stemness features, such as cycling rate,
self-renewal, and bi-potency, and could give rise to cTEC and mTEC lineages, or both (Table 1) [19].
cTECs (CD45−, EpCAM+, Ly51+, K8+, K5−, K14−) express a variety of self-antigens presented by
the major histocompatibility complex (MHC), which determine the diversity of the T-cell repertoire
through the process of positive selection. On the other hand, mTECs (CD45−, EpCAM+, Ly51−/low,
CD80high, K8−, K5+, K14+) express a different set of self-antigens producing a self-tolerant T-cell
repertoire through the elimination (so-called “negative selection”) of autoreactive T cells that bind
to medullary self-antigens with high affinity, through the process defined as “central tolerance”.
Moreover, mTECs are important constituents of Hassall’s corpuscles and regulate the production of
regulatory Tvcells (Tregs) (CD4+, CD25+, Foxp3+), which dampen immune responses in peripheral
tissues through the process of “peripheral tolerance” [18]. In this context, we can find thymic nurse
cells (TNCs), that are specialized epithelial cells, expressing cytokeratins 5 and 8 (K5 and K8), which
reside in the thymic cortex and are characterized by the expression of surface marker pH91. These
cells are able to incorporate up to 200 lymphocytes within specialized cytoplasmic vacuoles, and it is
thought that they play a pivotal role in T-cell development and MHC restriction [20–22]. Finally, as the
thymus originally develops from an endocrine area of the foregut, its cells are still able to produce
some hormones, such as thymulin, thymosin, thymopentin, and thymus humoral factor, which can
regulate thymic physiology [39].
Besides providing an initial overview of the structure, cellular organization and composition of
the thymus, in this review we describe in detail, and analytically discuss, the process of thymocyte
development into mature T cells, which includes the positive and negative selection steps, highlighting the
role of some key transcriptional factors, in both humans and mice. Finally, we provide some paradigmatic
examples of viral infections impacting the thymus in the first instance, and ultimately leading to aberrant
behavior of peripheral mature T cells in patients. The potential of therapeutic strategies aimed at boosting
thymopoiesis, in the context of viral infection of human pathogens, is discussed.
2. Thymocyte Development and Related Transcription Factors
The process of the T-cell maturation in the thymus represents one of the major events leading to
the functional and effective development of the entire immune system. Lymphocyte antigen receptors
are generated by DNA recombination, ensuring these cells are able to recognize and bind a large panel
of molecules of the most diverse provenience. In the lymphoid organs, T cells undergo sequential
steps of maturation that ultimately lead to mature T cells [40]. Within the process, it is possible to
discriminate between a first part, defined positive selection, which allows the survival of T cells
expressing a competent receptor. Eventually, self-reactive T cells are discarded (during negative
selection), generating a pool of mature and functional T cells.
In humans, immature T cells can express different T-cell antigen receptors (TCR) due to DNA
rearrangements, however, in the thymic cortex, cells are positively selected as they are able to recognize
host MHC molecules [41]. In the thymic cortex, the genes encoding for T-cell recombination-activating
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1 and 2 proteins (RAG1 and RAG2) are activated and operate the random recombination of V, D, and J
segments, which in turn lead to T cells expressing both a pre-TCR (bearing α and β chains) and the
co-receptors CD4 and CD8 (double-positive, DP stage). The TCRα chain rearrangement persists until a
productive interaction between the TCRαβ complex and the MHC complex of the cTECs occurs and
is recognized by the positive selection of the T cell. Thymocytes undergo apoptosis if they do not
generate a productive TCR rearrangement; in fact, the latter can interact with peptides presented by the
MHC, which are expressed by cells of the microenvironment. In this context, the interactions between
the T cells and the cTECs determine the fate of thymocytes [16,17,19] (Table 1). During the positive
selection stage, CD4+/CD8+ double positive (DP) thymocytes expressing TCRs poorly reactive against
self-peptide:MHC complexes receive signals to survive, further differentiate, and give rise to CD4 or
CD8 single positive (SP) cells, depending on their differential affinity toward either MHC class-II or
class-I, respectively [32–35]. Such a process, which we refer to as “positive selection” requires both
close contact and functional crosstalk with thymic stromal cells and occurs over a period of several
days (Figure 1). During positive selection, the cTECs express a signature of self-antigens pivotal for the
isolation of MHC-restricted T cells with functional TCR [42]. Among them, we can find Psmb11 (β5t),
a subunit of the tymo-proteasome, a specialized protein complex whose activity is required for the
generation of CD8-selection peptides [43]. On the other hand, cathepsin L and Prss16 (thymus-specific
serine protease-Tssp) exert the same activity for the CD4 T cells [32]. Following these processes, the SP
cells express the chemokine receptor CCR7, and they are attracted into the medulla where mTECs
produce high amounts of the CCR7 ligands, CCL19 and CCL21 [44].
The other thymic population, mTECs, mediate the second essential step required for the maturation
of T cells, negative selection. The cortical thymus homes T cells with productive rearrangements of
the TCR chains. However, these cells are able to interact with both non-self-antigens or self-antigens,
leading to potential auto-immunity events. Hence, these autoreactive cells have to be removed by
apoptosis during the process of “negative selection” [45].
Stritesky et al. have reported that 75% of negatively selected cells are deleted, at the DP stage, in
the thymus cortex, whereas the remaining 25% are deleted, at the SP stage, in the medulla [46]. These
findings are in line with those previously reported by McCaughtry et al., according to which, the clonal
deletion occurs in the thymus cortex by rare CD11c+ cortical dendritic cells, and elimination of such
cells impairs negative selection [47].
As an alternative, they can be subjected to “receptor editing” in the thymus [48–50], even though
Kreslavsky et al. denied such a mechanism [51]. The negative selection machinery thoroughly surveys
the T-cell repertoire and supplies the first defense against the autoimmunity mechanisms. In addition,
under circumstances whereby T cells escape from the central thymic control processes, they become
anergic in the periphery, or apoptotic after activation [52,53], by means of the peripheral tolerance
mechanism [48].
Upon positive selection, CD4 or CD8 T cells will express CCR7 and migrate into the medulla.
Herein, these cells will interact with medullary thymic epithelial cells (mTECs), which express high
levels of the CCL19 and CCL21 ligands; in the case of positive interaction, the deletion of autoreactive
T cells will be promptly executed [26]. mTECs can be considered to be the learning-center for the T
cells. Indeed, in order to mimic the expression of antigens that T cells could encounter in other tissues,
they are able to express a great variety of tissue-restricted antigens (TRAs) [19]. By doing so, mTECs
allow the deletion of cells that could recognize self-antigens that would otherwise be recognized in
peripheral districts (Figure 1).
Although the thymic medulla is essentially constituted by AIRE+ positive cells, it is characterized
by substantial heterogeneity. Miller et al. and Bornstein et al. have recently provided further insights
into such mTEC heterogeneity [54,55]. In particular, they identified a novel subset of mTECs, similar to
peripheral tuft cells, which are usually associated with the intestinal mucosal barrier and express mediators
of the taste transduction pathway and IL-25 [54,55]. The differentiation and the spatial localization of
these thymic tuft cells were strongly dependent on (homeodomain interacting protein kinase 2) HIPK2,
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an AIRE-binding partner. In addition, they showed that thymic tuft cells promoted the development and
polarization of iNKT2 within the thymus, establishing a type-2 thymic medullary microenvironment,
enriched in IL4, Pou2f3 (a transcriptional factor, marker of a rare chemosensory cell type found in the
gastrointestinal and respiratory tracts), and Trpm5 (mediator of the taste transduction pathway) [54].
Interestingly, medullary dendritic cells also contribute to the “tutoring” activity exerted by mTECs
cells. As such, this represents a strategy to emphasize the importance of TRA production by mTECs [40].
Indeed, this mechanism allows the deletion, mediated by dendritic cells and mTECs, of almost all T cells
recognizing self-antigen–MHC complexes [41]. Therefore, the process leading to the elimination (or
clonal deletion) of autoreactive T cells is defined as “negative selection”. One can easily envisage how
the process of T-cell selection is, in great part, regulated by TECs, which provide the microenvironment
to test the cross-reactivity of the randomly generated T cells, well before they are committed to leaving
the thymus. At this particular stage, these T cells will express a functional TCR without significant
reactivity to self-antigens, and they are “authorized” from the thymus to migrate to secondary lymphoid
organs (such as the spleen and lymph nodes) and eventually circulate throughout the body.
In mice, T-cell progenitors (Lin−, IL-7R+, Thy-1−, Sca-1low, c-Kitlow) derive from hematopoietic
stem cells of the bone marrow that migrate to the thymus via the bloodstream, and enter the thymus
close to the cortico–medullary junction (Table 3). Here, they generate double negative DN1 thymocytes
(CD117/c-KIT+, CD44+, CD25−) that evolve in DN2 (CD117/c-KIT+, CD44+, CD25+), and subsequently
in DN3 (CD117/c-KIT−, CD44−, CD25+). DN3 cells migrate to the sub-capsular zone of the thymic
lobules, where they undergo TCR rearrangements. The outward migration relies on the concerted
actions of CCL25 and CXCL12/CXCR4 that contribute to thymocyte proliferation and differentiation
towards DN4 (CD117/c-KIT−, CD44−, CD25−), and subsequently the double positive (DP) CD4+/CD8+
stage. In humans, three phenotypes of thymus-seeding progenitors (TSP) have been proposed:
(a) CD34high, CD45RAhigh, and CD7+ cells [29]; (b) Lin−, CD34+, CD10+,and CD24− cells [30]; and
(c) Lin−, CD34+, CD10−, CD45RA+, and CD62Lhigh cells [31]. Haddad et al. reported that CD34high,
CD45RAhigh, and CD7+ cells were able to migrate into thymic lobes in an ex vivo culture system [29].
The thymic progenitor differentiates into a DN compartment that is subdivided in DN1 (CD34−, CD38−,
CD1a+), DN2 (CD34−, CD38+, CD1a+), DN3 (CD34+, CD38+, CD1a+), and DN4, also defined as
immature single positive (CD3−, CD4+) [31].
Table 3. Surface antigen markers of T-cell development in humans and mice.
Progenitors DN1 DN2 DN3 DN4 DP SP
Human
CD34high,
CD45RAhigh,
CD7+
CD34−,
CD38−,
CD1a+
CD34−,
CD38+,
CD1a+
CD34+,
CD38+,
CD1a+
CD3−, CD4+ CD4
+,
CD8+
CD4+,
CD8− or
CD4−,
CD8+
Mouse
Lin−, IL-7R+,
Thy-1−,
Sca-1low
c-Kitlow
CD117/c-KIT+,
CD44+,
CD25−
CD117/c-KIT+,
CD44+,
CD25+
CD117/c-KIT−,
CD44−,
CD25+
CD117/c-Kit−,
CD44−,
CD25−
CD4+,
CD8+
CD4+,
CD8− or
CD4−,
CD8+
During T-cell development, the TCR loci are rearranged, with a large majority of cells being
converted into TCRαβ+ T cells. Moreover, different rearrangements at the Tcrδ, Tcrγ, and Tcrβ loci,
starting at DN2 and completed at DN3, will lead to γδ-T cell lineage. This differs from TCRαβ+ T
cells, which do require a peripheral activation in order to differentiate into effector cells; γδ-T cells are
intrinsically programmed to differentiate into effector cells.
In mice, the β-selection specifically occurs at the DN3 stage, where the progenitor cells rearrange
TCR loci to produce a functional β-chain; otherwise, development of the progenitor cells would not
progress and they would die instead [36]. In humans, the exact point at which β-selection occurs is still
controversial; it has been ascribed to the DP stage [37], the immature single positive stage [36,38], or the
CD1a+ DN3 stage [56]. The pre-TCR and Notch signaling pathway act synergistically in DN3 thymocytes
to trigger the β-selection process by, on one hand, reducing the gene expression of components of the
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RAG recombinase (Rag1 and Rag2) and, on the other hand, upregulating transferrin receptor CD71 (Tfrc)
and other trophic receptor genes [57]. As a consequence, thymocytes lose the cytokine receptor CD25
(IL-2Rα), becoming DN4 cells, which maturate into CD4+, CD8+ double positive (DP) cells through the
acquisition of expression of TCR, CD4, and CD8. It is worth noting how, in its entirety, the DN cell
compartment represents only 5% of total thymocytes, whereas the pool of DP cells constitutes 75–80%
of thymocytes, thus representing the most abundant cellular component of the thymus.
Specific key transcriptional regulators control the development of T cells in the thymus, including
Notch, Tcf-1, GATA-3, and Bcl11b (Table 4a). The initiation of the T-cell development program largely
depends on Notch signaling, and the thymic cortical environment is indeed abundant in Notch ligand,
mainly Delta-like ligand 4 (DLL4), which is strongly expressed by thymic stromal cells [58]. Upon
engagement of Notch1 by Delta-like ligand 4, a proteolytic release of intracellular Notch1 occurs.
Notch1 can translocate into the nucleus and binds and activates RBPJ, stimulating the expression
of Notch target genes [59]. The first T-cell specific genes include Tcf7 initially and, at a later stage,
GATA-3, and also Bcl11b, which regulate, in coordination with the same Notch, T-cell specification and
commitment fate [60–62].
During the initial phase of their development, T cells express PU.1, whose expression is completely
abrogated by the repressor GATA-3 during lineage commitment [63]. In particular, GATA-3 is a pivotal
transcription factor that drives T-cell development, acting as a potent repressor of B-cell potential, even
at low expression levels [64]. GATA-3, by its ability to repress PU.1 and Pax5, can inhibit both the B-cell
and myeloid developmental alternative paths [64]. Following the initial induction by Notch, GATA-3
expression is likely maintained by Myb and Tcf-1, both acting as positive regulators [65].
The progression of thymocytes toward the DN2 stage correlates with an increase of Bcl11b
expression, depending on the action of Notch, with the likely additional contribution of other
transcriptional factors (Table 4a) [66,67]. Bcl11b is required to complete the exclusion process, to restrict
and limit the possibility of non-T-cell fates [66–68], and also to inhibit residual NK cell lineage potential
in DN2 cells [69]. In particular, Bcl11b is able to decrease Kit expression, thus creating the DN2b
phenotype, likely by means of a direct competitive binding to a potential Kit enhancer region [70].
The CD4+/CD8+ lineage dichotomy is also controlled by the ThPOK and Runx3 transcriptional
factors, which exert opposite functions. ThPOK drives thymocyte development toward a CD4+ Th fate
and prevents the differentiation of thymocytes into CD8+ Cytotoxic T Lymphocytes (CTLs). Runx3
abolishes CD4 expression, inducing CTL-lineage differentiation instead. Other transcriptional factors
play a pivotal role for the CD4+ lineage; they include two E-box binding proteins (E-proteins), namely
E2A and HEB, GATA-3, and three transcriptional regulators belonging to the High Mobility Group
family (Tox, Tcf1, and Lef) [71]. Proteins containing HMG-box domains are involved in a variety of
physiologic protein–protein interactions and in various pathologic conditions, including cancer [72,73].
In addition, the action of ThPOK is critical even in already fully-differentiated, mature (peripheral)
T cells, as it counteracts the cytotoxic fate of MHC class II-restricted CD4+ T cells, even when they
differentiate into different Th effector subsets [74]. Runx3 is essential for CD8+ lineage, and its
expression is activated at the stage of CD8+ SP cells after positive selection and persists until the mature
CD8+ T-cell stage. In addition, Runx1, Runx3, and the zinc-finger Mazr can inhibit the expression of
ThPOK by binding specific silencer elements upstream of the ThPOK promoter (Table 4a) [75–78].
Recent findings report how NF-κB transcriptional activity is required for the later steps of T-cell
maturation [79–81]. More specifically, a strong activation of NF-κB occurs at the semi-mature stage,
after positive selection and before the migration of cells from the thymus. At this stage, the NF-κB
activity is critical for protecting cells from complex-II mediated death downstream of TNF-R1 in the
first instance. In addition, it sustains the maturation process so that thymocytes are made capable of
mounting a proliferative response, when and if stimulated through the antigen receptor [79].
The organogenesis, development, and the age-related, progressive involution of the thymus are
strictly dependent on TEC differentiation, homeostasis, and function. FoxN1 is the most important
transcriptional factor for TEC development. FoxN1 belongs to the fork-head (FOX) superfamily of
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transcription factors (TFs), which are implicated in developmental defects in vertebrates. In the
thymus, FoxN1 promotes the development of thymic epithelial progenitor cells (TEPC) into functional
medullary thymic epithelial cells (mTECs) and cortical thymic epithelial cells (cTECs) [82,83], and
maintains postnatal TEC homeostasis [84,85]. A lack of functional FoxN1 arrests the differentiation of
TEPC into mTEC and cTEC [86]. Likewise, the transcription factor p63 has an essential function in the
development of the thymus epithelium and epidermis [87], and is also required for the proliferation
and differentiation of TEPC [87,88]. Two p63 isoforms are known: TAp63, containing the N-terminal
transactivation domain, and ∆Np63, lacking this domain. ∆Np63 and FoxN1 are both highly expressed
in the fetal thymus [89,90], while in the adult thymus TECs expressing FoxN1+ and ∆Np63+ TECs
decrease with age [75,91,92].
The transcription factor AIRE is critical for thymus development, and is required for clonal
deletion of self-reactive T cells [93]. The AIRE gene seems to be expressed mostly in a small population
of mTEC (CD80hi MHC-IIhi) [94]. AIRE expression represents a hallmark for mTEC differentiation and
can be regulated by several factors including methylation, RANKL-RANK-mediated NF-κB activation,
the leukotriene β-mediated pathway, and perhaps miRNAs [94]. More specifically, AIRE is involved
in the expression of specific tissue-restricted antigens (TRA) such as insulin, casein, and muscular
acetylcholine receptor, as well as the expression of Xcl1, Ccr7, and Ccr4 ligands, which are essential
for the differentiation and functionalization of mTEC. It has been reported that, albeit with a low
affinity and no specificity toward any DNA sequence, AIRE binds to wide genome regions, including
promoters characterized by the presence of epigenetic repressive markers (i.e., methylated H3K27)
and the lack of permissive markers (methylated H3K4). On such promoters, AIRE contributes to
the induction of the transcription elongation by binding to a variety of transcriptional factors and
regulators, including Brd4 and Top1/2, and thus facilitating the recruitment of P-TEFb [93].
Recently, Takaba et al. have identified Fezf2 as a novel key transcriptional factor regulating
the expression of TRAs in mTEC (Table 4b) [95]. Interestingly, Fezf2-dependent TRA genes are
different from AIRE-dependent genes and include Fabp9 (usually highly expressed in the testes),
lipoprotein Apo-b and thrombin F2, well-known auto-antigens for which roles in different autoimmune
disease, such as atherosclerosis and systemic lupus erythematosus, have been described [95]. Fezf2 is
characterized by different DNA binding motifs, including one Eh1 domain and six C2H2-type zinc
finger-domains [96]. However, the molecular mechanisms by which it regulates the transcription of
TRA genes in mTEC remain to be elucidated.
Table 4. (a) Major transcriptional factors involved in thymocyte development; (b) Major transcriptional
factors involved in thymic stromal population development.
(a)
Transcriptional
Factor Cell Type Function References
GATA-3 Thymic NK cells Drive NK development from early thymocyteprecursors [3–5]
Notch DN3 cells Triggers the β-selection process [57–59]
GATA-3, Tcf7, Bcl11b T-cells Drives the early stage of T-cells development [60–65,81,82]
Bcl11b DN2 cells
Completes the exclusion process, limits
non-T-cell fates, inhibits NK lineages, decrease
Kit expression
[66–70]
PU.1, Pax5 Immaturelymphoid cells
If not inhibited by Gata-3, drive B-cell and
myeloid differentiation [63,64]
Myb, Tcf1 Immaturelymphoid cells Gata-3 positive regulators [65]
E2A, HEB, Gata-3,
Tox, Tcf1, Lef CD4 cells Drive CD4 lineage [71]
ThPOK CD4+/CD8+ Drives CD4+ Th fate and prevents thedifferentiation of thymocytes in CD8+ CTLs [71]
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Table 4. Cont.
(a)
Transcriptional
Factor Cell Type Function References
Mature T-cells Blocking the cytotoxic fate of MHC classII-restricted CD4+ T cells [74]
Runx3 CD4+/CD8+ Abolishes CD4 expression inducingCTL-lineage differentiation [71]
Runx1, Runx3, Mazr CD8 cells Inhibit the expression of ThPOK [75–78]
NF-κB Positive selectionsurvived T-cells Required for late maturation [79,80]
(b)
Transcriptional
Factor Cell Type Function References
FoxN1 TEPC
Development of TEPC in mTECs and cTECs;
maintains postnatal TEC homeostasis; its lack
arrests TEPC differentiation
[82–86]
p63 TEPC
Required in epithelial development of thymus
and epidermis; required for proliferation and
differentiation
[87,88]
AIRE CD80
hi MHC-IIhi
mTECs
Critical for thymus development, required for
clonal deletion of self-reactive T cells; involved
in expression of TRA
[93,94]
Fezf2 mTECs Regulates TRAs expression different from thoseof AIRE [95,96]
Pou2f3 Thymic tuft cells Essential for the maturation of thymic tuft cells [54]
3. Immunological Consequences of Viral Infections of the Thymus
The thymus is an organ commonly targeted by infectious pathogens such as viruses, bacteria, and
fungi. Such infections may induce phenotypic and functional changes within the thymus, including
alterations of proliferation, death, secretion, migration, and differentiation of thymocytes (Figure 1,
Table 5). The behavior of mature, peripheral T-lymphocytes can be equally affected [97]. One of
the most common effects on thymic function caused by pathogen infections is the impairment of
the central tolerance process in thymocytes, through the impairment of both positive and negative
selection processes. Nevertheless, the recruitment of antimicrobial immunity directly to the thymus
can help to resolve local infection [98].
Table 5. Impact of viruses on thymus.
Virus Target Effect Reference
MLV/HBV/LCMV TEC/TEC stem cells Impaired tolerance [99–103]
HIV/SIV DP cells, thymocytes Thymic atrophy; DN to DP block [104–112]
H7N7/HSN1/H1N1 Respiratory DCs in lungbefore thymic migration Thymic atrophy [113,114]
IAV Thymocytes Increased INFγ production by NKs;increased T-cells apoptosis [115]
Measles TEC/Myelomonocyticcells Reduced DP cells [116–119]
HTLV-1 TEC Virus transmission to CD4; impaired geneexpression [120]
CMV mTEC Infects epithelial cells rather thanhematopoietic cells [121]
CV-B TEC/mTEC
Increased IL-6/GM-CSF/LIF production;
increased IgF2 production and autoimmune
diabetes
[122–124]
RSV Thymocytes Reduced TREC [125]
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Tolerance to pathogens occurs frequently during viral infection. Specifically, it has been shown
that infecting mice with thymotropic murine leukemia virus (MLV) very soon after birth can elicit
T-cell tolerance to virus antigens [99,100]. Similarly, lymphocytic choriomeningitis virus (LCMV),
following infection in mice, is primarily restricted to thymic CD4+ T cells, with only marginal
involvement of cytotoxic CD8+ T cells, causing suppression of virus-specific T cell responses [101,102].
Such chronic infection could be eliminated by adoptive transfer of CD8+ T cells obtained from
LCMV-immunized mice. Even more interestingly, the viral clearance induced the re-acquisition of
LCMV-specific CTL responses, indicating that continuous presence of the antigens in the thymus can
trigger tolerance [100,102,103]. Similar to MLV and LCMV infections, prenatal intrauterine infection
with HBV (Hepatitis B virus) induces T-cell tolerance to viral proteins [126] and children born from
HBV-infected mothers are more likely to become chronic carriers of HBV [127], suggesting once again
how the presence of viral proteins within the thymus can induce an HBV-specific T-cell tolerance.
Of note, both MLV and HBV are capable of infecting TEC cells [99,128], and the observation of a
rapid turnover of TECs could likely support the hypothesis that these viruses can continually infect
new TECs, or reside in thymic epithelial stem cells [100]. Altogether, these data indicate that direct
thymic infections by viruses can severely alter T-cell selection and induce tolerance against invading
pathogens, with the consequent effect of impairing ongoing immunity.
Takamura et al., have analyzed the effects of Friend virus (FV) infection on the thymus in mice [129].
Friend virus is a murine-tropic retrovirus constituted by two gamma-retroviruses, whose replication
occurs mainly in fully dividing hematopoietic cells, which leads to the exhaustion of antigen-specific
CD8+ T cells. They found that upon infection, FV spread to, and persisted within, the thymus,
infecting and replicating mainly into DN thymocytes that will then proliferate and develop into DP
cells. Interestingly, the viral antigens were expressed in all DC subsets as well as in mTECs and cTECs.
In addition, they found that FV infection had no impact on the number and frequency of thymocyte
populations, and also did not alter thymic architecture, yet caused the clonal deletion of FV-specific
thymocytes through the direct deletion action of DC and cTEC cells expressing viral antigens. However,
they showed that in FV-chronically-infected mice, FV-reactive CD8+ T cells, freshly primed upon
chronic infection, were nevertheless able to differentiate into memory CD8+ T cells, with a stronger
functionality, as compared to the exhausted memory CD8+ T cells at the peripheral level [129].
It is also worth underlining the evasion strategies of anti-viral CD8+ T-cell-mediated immunity
adopted by murine retrovirus through the regulation of central and peripheral tolerance. In the
context of FV infection, we can summarize the following points: (1) during the acute phase of infection,
FV-infected-erythroblasts expressing PD-L1 induce the exhaustion of CD8+ T cells in the periphery;
(2) FV spreads to the thymus and induces the expression of viral antigens on thymic DCs and TECs;
(3) the presentation of viral antigens by DCs and TECs in the thymus blocks the production of
pathogen-reactive naïve CD8+ T cells as source of functional memory CD8+ T cells.
Induction of virus-specific central tolerance is not a characteristic unique to the Friend virus.
Besides the aforementioned mechanism, it has been reported that neonatal infection with either the
Gross murine leukemia virus (G-MuLV) or the Moloney murine leukemia virus (MMLV) determines a
strong viral replication within the thymus, ultimately inducing a life-long immune non-responsiveness
to viral antigens [129].
Severe atrophy of the thymus is a common feature observed during several acute infections and
involves mainly CD4+ CD8+ DP thymocyte subsets. The depletion of the double positive thymocyte
(DP) compartment has been reported in a wide variety of bacterial, protozoal, and viral infections,
including Human Immunodeficiency Virus-1, HIV-1 infection. Thymic structural and functional
alterations have been previously reported in HIV infection [104]. Specifically, in HIV-1 infected infants,
characterized by a fast onset of Acquired ImmunoDeficiency Syndrome, AIDS, evidence of thymic
dysfunctions, related to an altered architecture of the thymus, have been found [105]. It is well known
that HIV-1 and Simian Immunodeficiency Virus (SIV) are able to infect the thymus [106,107], thus
inducing thymic alterations and clinically relevant conditions. Upon specific infections, atrophy of the
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thymus is highly frequent in patients and is usually characterized by a block in thymocyte maturation
(from DN to DP thymocytes), ultimately leading to a progressive and massive reduction of DP and
SP (CD4+, CD8−) thymocytes [105,108]. In HIV-1-infected infants, the strong decrease of CD4+ and
CD8+ T cells in peripheral blood is caused by a massive reduction of thymic DP cells [109]; similar
observations have been obtained in SIV-infected macaques [110,111]. Recently, our research group
has developed and characterized a murine transgenic model (Tat-Tg mice), specifically expressing the
HIV-1 Tat protein in the lymphoid tissues. Strikingly, this transgenic line was mainly characterized
by a marked atrophy of the thymus, characterized by an increase of DN4 thymocytes subset coupled
with a massive reduction of the DP subset. This phenotype showed typical features of pediatric and
severe AIDS, suggesting that Tat represents the most important etiopathogenic viral protein involved
in AIDS-related thymic atrophy [112]. More specifically, an aberrant increase of p65/NF-κB activity
was observed in thymocytes derived from Tat-Tg mice, likely due to both the pro-activating interaction
between Tat and p65 [130] and the inhibitory interaction with IκB-α [131–133], de-regulating the
expression of several key cytokines/chemokines and microRNA-181a-1 and, thus, affecting thymocyte
differentiation from DN4 toward DP. It is likely that the effects of these alterations resulted in an
increased DN4 sub-population of the DN compartment, associated with the massive loss of peripheral
CD4+ and CD8+ T cells.
Interestingly, it has been shown how, following the infection of respiratory DCs in the lung, highly
pathogenic influenza viruses (H7N7, H5N1, and H1N1v) can affect the homing process of DCs into
the thymus. In particular, infected respiratory DCs migrated into the thymus, promoting the thymic
viral spread and leading to alterations of the antigen presentation, which is essential for the functional
development of thymocytes. Thus, infected dendritic cells can interfere with the T-lymphocyte selection
processes into the thymus, leading to thymic atrophy [113,114].
It has been also shown in mice that Influenza A virus (IAV) infection led to severe thymic atrophy
caused by increased thymic T-cell apoptosis and suppressed proliferation, through a mechanism
involving IFN-γ production by NK cells [115].
A Severe Combined ImmunoDeficiency, SCID-humanized mouse model infected with different
strains of the Measles virus showed a productive infection occurring in thymic epithelial and
myelo-monocytic cells, leading to a rapid depletion of CD4+CD8+ double positive (DP) thymocytes
by apoptosis, and contributing to a long-term alteration of immune responses [116]. Consistent with
these observations, in vitro infection of thymic epithelial cells with Measles virus induced terminal
differentiation and apoptosis associated with the production of type-1 interferon (IFN-1) [117,118].
In ex vivo human thymus-derived organotypic cultures, thymocytes were susceptible to Measles virus
infection with a higher grade of replication in immature CD4+/CD8+ double positive cells. Furthermore,
the susceptibility to infection correlated with both the level of expression of the Measles virus receptor
CD150 and the age of thymus donors [119].
Barros et al. showed that TECs express the receptor for HTLV-1 virus and can be infected by this virus,
impairing the expression of anti-apoptotic genes, chemokines, and adhesion molecules, even though the
expression profile of antigen presentation molecules remained unchanged. Interestingly, infected TEC
cells transmitted the HTLV-1 virus to CD4+ cells, functioning as a reservoir of the infection [120]. In a
SCID-hu mouse, CMV has been found to be able to infect the thymus in vivo [121]. In particular, the
majority of virus-infected cells were epithelial cells, mainly localized in the thymic medulla, rather than
the cortical region [121]. Type-B Coxsackievirus (CV-B) has been shown to infect TECs in vitro, and to
trigger strong production of IL-6, GM-CSF, and leukocyte migration inhibition factor (LIF) in infected
cells [122]. In addition, evidence that Coxsackievirus infection of a murine mTEC line induced a dramatic
decrease in both Igf2 gene transcription and IGF-2 production [123] strongly supports the hypothesis that
CV-B infection of the thymus could disrupt central self-tolerance to the insulin/insulin-like growth factor
family members, contributing to the development of auto-immune diabetes [124].
Furthermore, a significant reduction of T-cell Receptor Excision circles, TREC counts, an episomal
DNA generated during the re-arrangement of thymic T-cell receptors, and as such a reliable marker for
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thymus activity, was observed in children hospitalized for respiratory syncytial virus (RSV) infection,
as opposed to healthy individuals [125]. This suggests that RSV infection might exert a strong impact
on thymus activity, despite the fact that a direct RSV infection of thymus has not been experimentally
demonstrated, so far.
Myasthenia gravis (MG) is a prototype autoimmune disease where the muscle weakness is largely
induced, and consequent to, the production of autoantibodies, which bind to the muscle postsynaptic
junction, disrupting the function and proper activity of acetylcholine receptors (AChR) [134]. To date,
it is commonly accepted that the primary site of this autoimmune disorder is the thymus. Although
the etiopathogenesis of MG is still unclear, affected individuals show thymic hyperplasia, thymoma,
or thymic involution. In MG patients with a hyperplastic thymus, the gland appears to be mainly
composed of B-lymphocytes that are either organized into ectopic germinal centers (GCs) or distributed
throughout the thymic medulla. Despite this strong morphological evidence, the key molecular factors
triggering and promoting the development of MG with thymic follicular hyperplasia remain to be
discovered. According to the scientific evidence collected so far, the major MG-dependent thymic
alterations affect the fitness and activity of natural regulatory T cells. Likewise, fewer regulatory T
cells can be observed in the periphery. In addition, MG thymic effector T cells are less responsive to
Treg repression, contributing to the observed pro-inflammatory thymic environment [135]. In general
terms, viral or bacterial infections leading to chronic inflammation of the thymus may trigger the
development of autoimmunity, thereby contributing to the pathogenesis of MG [136,137]. Consistent
with this hypothesis, one of the major candidates as an environmental risk factor for MG is Epstein-Barr
Virus, EBV infection [137], and recent works suggest that EBV infection contributes to the pathogenesis
of MG within the thymus through a sustained stimulation of TLR-7 and TLR-9, thus, de-regulating
innate immunity [138,139]. Furthermore, a recent study shows how the Parvovirus B19 infection is
strongly related to thymic hyperplasia and thymic hyperplasia-associated MG [140].
4. Conclusions and Perspectives
To date, the role of the thymus as a primary lymphoid organ responsible for the generation
of mature T cells is well known and has been generally accepted. In view of its function, the
microenvironmental compartment of the thymus is extremely complex, characterized by a wide variety
of cells and matrix molecules that orchestrate thymocyte maturation into CD4+ or CD8+ single-positive
(SP) T cells. Despite the significant advancements achieved in recent decades, many aspects, including
the molecular mechanisms, regulating (both in physiological and pathological conditions) the activity
of this gland, and thymocyte differentiation, still need to be further investigated. More specifically,
novel cell subsets, including novel immature T cells, thymic epithelial cells (TEC), macrophages,
dendritic cells, and fibroblasts within the thymus microenvironment could be identified, as well as
novel transcriptional factors, microRNAs, and specific cytokines governing T-cell maturation.
Among the environmental factors, pathogens can severely affect thymocyte development and
migration to other lymphoid tissues, causing severe thymic atrophy and aberrant behavior of peripheral
T-lymphocytes, inducing the typical “cytokine storm”, characterized by chronically elevated or excessive
production of pro-inflammatory cytokines, associated with chronic inflammation, as observed in
Myasthenia gravis. More efforts are required to study thymus development and function upon
viral, bacterial, fungal, and protozoan infections, which could unveil novel mechanisms of aberrant
thymocyte development operating under the biological pressure of specific infective agents. This
aspect would be particularly relevant for envisaging novel therapeutic tools and strategies aimed,
for instance, at expanding the thymic stromal compartment and improving thymopoiesis in order to
counteract the action of human pathogens.
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